Bicycle Partners With Biogen Spinout Against Rare Blood Disorders
Executive Summary
Bicycle Therapeutics and Biogen spinoff Bioverativ have teamed up to develop novel treatments for hemophilia and sickle cell disease under a multi-million-dollar discovery and development agreement.